What is Machaon Diagnostics?
Machaon Diagnostics operates as a specialized laboratory and clinical research organization (CRO) with a distinct focus on rare diseases. The company offers a comprehensive suite of laboratory services, including expertise in coagulation, genetics, and hyperinflammatory testing. Beyond diagnostics, Machaon Diagnostics provides critical support for clinical research through innovative services such as central laboratory operations, and a unique subject, site, and sample finder. Their core mission is to accelerate patient outcomes by delivering the nation's fastest laboratory results, underpinned by a commitment to speed, quality, and consistency. Machaon Diagnostics is a trusted partner for leading medical centers and global pharmaceutical companies, providing essential diagnostic services for complex medical challenges.
How much funding has Machaon Diagnostics raised?
Machaon Diagnostics has raised a total of $897K across 2 funding rounds:
Debt
$350K
Debt
$547K
Debt (2020): $350K with participation from PPP
Debt (2021): $547K led by PPP
What's next for Machaon Diagnostics?
The recent major strategic investment suggests Machaon Diagnostics is poised for significant expansion and development. This infusion of capital, following earlier debt financing, likely signals a strategic pivot towards scaling operations, enhancing research capabilities, or broadening its service offerings within the rare disease and clinical research sectors. The company's emphasis on speed and quality in delivering critical diagnostic results positions it for continued growth and deeper partnerships with pharmaceutical giants and top-tier medical institutions.
See full Machaon Diagnostics company page
